Literature DB >> 22257239

The formation of P particle increased immunogenicity of norovirus P protein.

Ming Tan1, Xi Jiang.   

Abstract

As a commentary on a recently published paper in Immunology, this article summaries the principle of norovirus P particle as a promising vaccine against noroviruses. It emphasizes the importance of P particle formation in the immune enhancement of the vaccine and methods for production/verification of high quality P particles which may be easily neglected by researchers.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257239      PMCID: PMC3372754          DOI: 10.1111/j.1365-2567.2012.03555.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles.

Authors:  Ming Tan; Ping-An Fang; Ming Xia; Teepanis Chachiyo; Wen Jiang; Xi Jiang
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

3.  The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Xi Jiang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein.

Authors:  Ming Tan; Jarek Meller; Xi Jiang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Structural basis for the receptor binding specificity of Norwalk virus.

Authors:  Weiming Bu; Aygun Mamedova; Ming Tan; Ming Xia; Xi Jiang; Rashmi S Hegde
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Structural basis for the recognition of blood group trisaccharides by norovirus.

Authors:  Sheng Cao; Zhiyong Lou; Ming Tan; Yutao Chen; Yijin Liu; Zhushan Zhang; Xuejun C Zhang; Xi Jiang; Xuemei Li; Zihe Rao
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus.

Authors:  Jae-Mun Choi; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-02       Impact factor: 11.205

8.  Noroviral P particle: structure, function and applications in virus-host interaction.

Authors:  Ming Tan; Pingan Fang; Teepanis Chachiyo; Ming Xia; Pengwei Huang; Zhaoyin Fang; Wen Jiang; Xi Jiang
Journal:  Virology       Date:  2008-10-16       Impact factor: 3.616

9.  The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Rashmi S Hegde; Xi Jiang
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.

Authors:  Ming Tan; Ming Xia; Yutao Chen; Weiming Bu; Rashmi S Hegde; Jarek Meller; Xuemei Li; Xi Jiang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more
  8 in total

Review 1.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 2.  Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.

Authors:  Ming Tan; Xi Jiang
Journal:  Nanomedicine (Lond)       Date:  2012-06       Impact factor: 5.307

3.  Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.

Authors:  Jacob Kocher; Tammy Bui; Ernawati Giri-Rachman; Ke Wen; Guohua Li; Xingdong Yang; Fangning Liu; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Polyvalent complexes for vaccine development.

Authors:  Leyi Wang; Pengwei Huang; Hao Fang; Ming Xia; Weiming Zhong; Monica M McNeal; Xi Jiang; Ming Tan
Journal:  Biomaterials       Date:  2013-03-15       Impact factor: 12.479

5.  Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.

Authors:  Jacob Kocher; Lijuan Yuan
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 6.  Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens.

Authors:  Erin A Almand; Matthew D Moore; Lee-Ann Jaykus
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

7.  Recent advancements in combination subunit vaccine development.

Authors:  Ming Tan; Xi Jiang
Journal:  Hum Vaccin Immunother       Date:  2017-01-02       Impact factor: 3.452

8.  Norovirus P particle efficiently elicits innate, humoral and cellular immunity.

Authors:  Hao Fang; Ming Tan; Ming Xia; Leyi Wang; Xi Jiang
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.